1 Allan G, Todd D, Meehan B, et al. Novel porcine circoviruses from pigs with wasting disease syndromes[J]. Vet Rec, 1998, 142(17): 467~468.2 Beach N M, Meng X J. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)[J]. Virus Res, 2012, 164(1~2): 33~42.3 Blanchard P, Cariolet R, Baudouard M A, et al. Protection of swine against post-weaning multisystemic wasting syndrome(PMWS) by porcine circovirus type 2 (PCV2) proteins[J]. Vaccine, 2003, 21(31): 4565~4575.4 Chae C. Postweaning multisystemic wasting syndrome: A review of aetiology, diagnosis and pathology[J]. Vet J, 2004, 168(1): 41~49.5 Cheung A K. Identification of an octanucleotide motif sequence essential for viral protein, DNA, and progeny virus biosynthesis at the origin of DNA replication of porcine circovirus type 2[J]. Virology, 2004, 324(1): 28~36.6 Fenaux M, Opriessnig T, Halbur P G, et al. Two amino acid mutations in the capsid protein of type 2 porcine circovirus(PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo[J]. Journal of Virology, 2004, 78(24): 13440~13446.7 Hamel A L, Lin L L, Nayar G P. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs[J]. J Virol, 1998, 72: 5262~5267.8 Hasslung F, Ladekjaer-Hansen A S, Nielsen J, et al. Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2[J]. Vet Microbiol, 2005, 106(1~2): 49~60.9 Huang L P, Lu Y H, Wei Y W, et al. Development of a blocking ELISA for detection of serum neutralizing antibodies against porcine circovirus type 2[J]. J Virol Methods, 2011, 171(1): 26~33.10 Kim J, Jung K, Chae C. Prevalence of porcine circovirus type 2 in aborted fetuses and stillborn piglets[J]. Vet Rec, 2004, 155(16): 489~492.11 Mahe D, Truong C, Le Cann P, et al. Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes[J]. J Gen virol, 2000, 81(7): 1815~1824.12 Mankertz A, Mankertz J, Wolf K, et al. Identification of a protein essential for replication of porcine circovirus[J]. Gen Virol, 1998, 79(2): 381~384.13 Mankertz A, Folch J M, Jestin A, et al. Characterisation of PCV-2 isolates from Spain, Germany and France[J]. Virus Res, 2000, 66(1): 65~77.14 Patterson A R, Johnson J, Ramamoorthy S, et al. Comparison of three enzyme-linked immunosorbent assays to detect Porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates[J]. J Vet Diagn Invest, 2008, 20(6): 744~751.15 Pogranichniy R, Yoon K J, Yaeger M, et al. Possible prevention of PMWS using inactivated PCV2 vaccine in CD pig[A]. In: Proceedings of the 18th IPVS Congress, 2004.16 Sedlik C, Sarraseca J, Leclerc C. Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells[J]. Pro Natl Acad Sci USA, 1997, 94(14): 7503~7508.17 Shang S B, Li Y F, Guo J Q, et al. Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2[J]. Res Vet Sci, 2008, 84(1): 150~157.18 Shibahara T, Sato K, Ishikawa Y, et al. Porcine circovirus induces B lymphocyte depletion in pigs with wasting disease syndrome[J]. J Vet Med Sci, 2000, 62(11): 1125~1131.19 Stevenson L S, Douglas A, Mcnair I, et al. T lymphocyte epitope mapping of porcine circovirus type 2[J]. Viral Immunology, 2007, 20(3): 389~397.20 Valenzuela P, Rutter W J, Hall B D. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast[J]. Nature, 1982, 298(5872): 347~350.21 Yu S, Kitikoon P, Halbur P G, et al. Porcine circovirus type 2(PCV2) distribution and replication in tissues and immune cells in early infected pigs[J]. Vet Immunology and Immunopathology, 2007, 115(3~4): 261~272. |